Skip to ContentSkip to Navigation
About us Latest news News News articles

Dietary carbohydrate digestion and fermentation: relevance for prevention of type 2 diabetes

13 September 2010

PhD ceremony: Mr. H. Wang, 16.15 uur, Academiegebouw, Broerstraat 5, Groningen

Thesis: Dietary carbohydrate digestion and fermentation: relevance for prevention of type 2 diabetes

Promotor(s): prof. R.J. Vonk

Faculty: Medical Sciences

 

Consumption of carbohydrates is associated with the prevention of type 2 diabetes. Two important physiological processes thereby play a role: 1. slow digestion in the small intestine which leads to a low blood glucose response after a meal and 2. the fermentation of non-digestible carbohydrates in the large intestine. It is supposed that the fermentation process plays a role by means of the production of short chain fatty acids (SCFA).

Firstly, we have developed a mathematical model to examine non-invasively the contribution of digestion as well as fermentation after intake of carbohydrate-rich meals in humans. The fermentation of non-digestible carbohydrates, inclusive dietary fiber, is not investigated in detail until now. This is why we also developed an analytical method to be able to measure the SCFA profile in blood and in urine. The test meals were labeled with stable isotopes which enabled us to relate the SCFA profile to the investigated test meals. We found that SCFA profiles in plasma and urine could be changed by different non-digestible carbohydrates.

Furthermore, we found that healthy men had a lower glucose response and lower inflammation markers in blood after breakfast when they had eatennon-digestible carbohydrates in the evening. The higher hydrogen excretion in breath and the higher bloodSCFA concentrations in the morning strongly suggest that fermentation in the large intestine is responsible for these beneficial effects with SCFAs as the intermediary factor.

Manipulation of fermentation of carbohydrates in the large intestine seem to be a promising approach for the prevention of type 2 diabetes.

 

 

Last modified:13 March 2020 01.14 a.m.
View this page in: Nederlands

More news

  • 27 August 2024

    UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling

    Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...

  • 17 July 2024

    Veni-grants for ten researchers

    The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.

  • 16 July 2024

    Medicine still subjects to male bias

    Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.